Abstract
Objectives Activation of the immune-inflammatory response system (IRS) and a deficiency in the compensatory immunoregulatory system (CIRS), neuronal injuries, and alterations in the glutamate receptor (GlutaR), aquaporin-4 (AQP4), and heat shock protein 60 (HSP60) are involved in delirium. Increased serum levels of neurofilament protein (NFP), glial fibrillary acidic protein (GFAP) and myelin basic protein (MBP) are biomarker of neuronal injury and post-surgery cognitive impairments. Polyreactive antibodies (PAbs) contribute to the development of immune-mediated disease. This investigation delineates whether elevated IgA and IgG reactivity against those self-antigens is associated with enhanced IRS responses and delirium severity.
Methods We measured peak Delirium Rating Scale (DRS) scores on days 2 and 3 following surgery in 59 hip fracture older adults, and IgA/IgG antibody levels against MBP, NFP, GFAP and myelin oligodendrocyte glycoprotein (MOG), GlutaR, N-Methyl-D-Aspartate receptor (NMDAR), APQ4 and HSP60.
Results The IgA antibody levels against those self-antigens, especially GFAP, MBP and HSP60, strongly predict peak DRS scores on days 2 and 3 post-surgery. IgA reactivity against NMDAR and baseline DRS scores explained 40.6% of the variance in peak DRS scores, whilst IgA against NMDAR, IgG against MBP and age explained 29.1% of the variance in the IRS/CIRS ratio. There was no correlation between DRS scores and IgG directed against these self-antigens.
Conclusions Increased IgA levels against neuronal self-antigens, AQP4, and HSP60 are risk factors for delirium. PAb-associated breakdown of immune tolerance, IRS activation and injuries in the neuronal cytoskeleton, oligodendrocytes, astrocytes, glial cells, and myelin sheath are involved in the pathophysiology of delirium.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported by a Ratchadapisek Sompoch Endowment Fund of the Faculty of Medicine, Chulalongkorn University (RA62/014).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Approval for the study was obtained from the Institutional Review Board of the Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand (registration number 528/61), in compliance with the International Guideline for Human Research protection, as required by the Declaration of Helsinki, was conducted according to Thai and international ethics and privacy laws. Written informed consent was obtained before the study from the patients or their guardians (first-degree family members).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
(14) Michael Maes | Stats (researchgate.net), Michael Maes - Google Scholar, Yanin.T{at}chula.ac.th, Sarun.Ta{at}chula.ac.th, Sunee.S{at}chula.ac.th, drari{at}msn.com
Data Availability
The dataset generated during and/or analyzed during the current study will be available from Prof. Dr. Michael Maes upon reasonable request and once the dataset has been fully exploited by the authors.